Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
3 hedge funds and large institutions have $48K invested in Nemaura Medical, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
4,700% more capital invested
Capital invested by funds: $1K → $48K (+$47K)
200% more funds holding
Funds holding: 1 → 3 (+2)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$23.2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$7.02K |
| 3 |
OIA
Optimum Investment Advisors
Chicago,
Illinois
|
+$6.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
NMRD Hedge Fund Activity: Q1 2020 in Review
3 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2020, worth a combined $48K — up 4,700% from $1K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NMRD positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $23.2K. The largest seller was Deutsche Bank, exiting entirely with an estimated $1K sold.
- 3 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2020, up from 1 in Q4 2019.
- Funds reported $48K of Nemaura Medical, Inc. Common Stock stock for Q1 2020, up 4,700% quarter-over-quarter.
- 3 funds opened new Nemaura Medical, Inc. Common Stock positions in Q1 2020 and 1 closed out, a net change of +2 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q1 2020 was UBS Group, an estimated $23.2K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q1 2020 was Deutsche Bank, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2020.